ArticleAntimicrobial agents and chemotherapy2003

Experimental study of LY333328 (oritavancin), alone and in combination, in therapy of cephalosporin-resistant pneumococcal meningitis.

Carmen Cabellos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.